mucin
Trade name: theratope
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 1999 (NCT00003638)
Timeline
Indications
Studied for
Mechanism of action
- Mucin-1Immunity, active
MUC1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- clustered stn-klh conjugate
- sialyl-tn antigen-keyhole-limpet hemocyanin conjugate
- stn(c)-klh
- stn-klh
- theratope
- theratope
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00046371 | Phase 2 | Aug 1, 2002 | Cascadian Therapeutics Inc. |
| NCT00003638 | Phase 3 | Jan 1, 1999 | Cascadian Therapeutics Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cascadian Therapeutics Inc. | For profit | 2 | 2 | 2 | 1999 |
1 organizations
Page 1 / 1